Bisphosphonates as antialveolar macrophage therapy in pulmonary langerhans cell histiocytosis?
Brown
R E
RE
Division of Laboratory Medicine, Geisinger Medical Center, Danville, Pennsylvania, USA. rebrown@geisinger.edu
D015703:Antigens, CD / Q000032:analysis; D015214:Antigens, Differentiation, Myelomonocytic / Q000032:analysis; D002403:Cathepsins / Q000378:metabolism; D004164:Diphosphonates / Q000627:therapeutic use*; D006646:Histiocytosis, Langerhans-Cell / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D008168:Lung / Q000378:metabolism; D016676:Macrophages, Alveolar / Q000187:drug effects*; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism; D000097382:CD68 Molecule
D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D002403:Cathepsins; D004164:Diphosphonates; D007703:Peptidyl-Dipeptidase A; C067980:CD68 antigen, human; D000097382:CD68 Molecule